Asthma drug tested for stubborn nasal polyps – trial cut short
NCT ID NCT04157335
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 study tested the drug benralizumab in 295 adults with severe nasal polyps and eosinophilic chronic sinusitis. Participants received injections of benralizumab or a placebo every 4 to 8 weeks for about a year. The goal was to see if the drug could shrink polyps and improve nasal blockage and sense of smell. The trial was terminated early, so the full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Benralizumab (a biologic drug given as an injection)
What this could lead to
If successful, this could point toward a new treatment option for people with severe nasal polyps and chronic sinusitis.
What could go wrong
The trial was terminated early, so results are limited. Benralizumab is already approved for asthma, but its effect on nasal polyps is still uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Huntington Beach, California, 92647, United States
-
Research Site
Grand Junction, Colorado, 81501, United States
-
Research Site
Gainesville, Florida, 32605, United States
-
Research Site
Louisville, Kentucky, 40220, United States
-
Research Site
White Marsh, Maryland, 21162, United States
-
Research Site
The Bronx, New York, 10461, United States
-
Research Site
White Plains, New York, 10605, United States
-
Research Site
Tulsa, Oklahoma, 74136, United States
-
Research Site
Bethlehem, Pennsylvania, 18017, United States
-
Research Site
Fort Worth, Texas, 76109, United States
-
Research Site
McKinney, Texas, 75070, United States
-
Research Site
St. George, Utah, 84790, United States
-
Research Site
Richmond, Virginia, 23235, United States
-
Research Site
Bellingham, Washington, 98225, United States
-
Research Site
Milwaukee, Wisconsin, 53228, United States
-
Research Site
Buenos Aires, C1121 ABE, Argentina
-
Research Site
Buenos Aires, C1414AIF, Argentina
-
Research Site
Ciudad de Buenos Aire, C1425BEN, Argentina
-
Research Site
San Fernando, B1646EBJ, Argentina
-
Research Site
Herston, 4029, Australia
-
Research Site
Melbourne, 3004, Australia
-
Research Site
Spearwood, 6163, Australia
-
Research Site
Brussels, 1200, Belgium
-
Research Site
Ghent, 9000, Belgium
-
Research Site
Leuven, 3000, Belgium
-
Research Site
Plovdiv, 4001, Bulgaria
-
Research Site
Sofia, 1303, Bulgaria
-
Research Site
Sofia, 1606, Bulgaria
-
Research Site
Quillota, 2260000, Chile
-
Research Site
Santiago, 7500588, Chile
-
Research Site
Santiago, 8150000, Chile
-
Research Site
Talca, 3481349, Chile
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100191, China
-
Research Site
Beijing, 100730, China
-
Research Site
Changchun, 130061, China
-
Research Site
Changsha, 410008, China
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chengdu, 610072, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Foshan, 528000, China
-
Research Site
Guangzhou, 510000, China
-
Research Site
Guangzhou, 510180, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Jinan, 250014, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanjing, 210029, China
-
Research Site
Nanning, 530021, China
-
Research Site
Qingdao, 266071, China
-
Research Site
Shanghai, 200065, China
-
Research Site
Shanghai, 200092, China
-
Research Site
Tianjin, 300050, China
-
Research Site
Ürümqi, 830054, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Xi'an, 710004, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Yantai, 264000, China
-
Research Site
Marseille, 13005, France
-
Research Site
Toulouse, 31059, France
-
Research Site
Budapest, 1033, Hungary
-
Research Site
Budapest, 1046, Hungary
-
Research Site
Győr, 9024, Hungary
-
Research Site
Kaposvár, 7400, Hungary
-
Research Site
Siófok, 8600, Hungary
-
Research Site
Székesfehérvár, 8000, Hungary
-
Research Site
Tatabánya, 2800, Hungary
-
Research Site
Catanzaro, 88100, Italy
-
Research Site
Pisa, 56124, Italy
-
Research Site
Roma, 00161, Italy
-
Research Site
Roma, 00168, Italy
-
Research Site
Chiba, 262-0015, Japan
-
Research Site
Fujisawa-shi, 251-0052, Japan
-
Research Site
Hiroshima, 734-8551, Japan
-
Research Site
Ichikawa-shi, 272-0143, Japan
-
Research Site
Iida-shi, 395-8505, Japan
-
Research Site
Kawasaki-shi, 211-0063, Japan
-
Research Site
Kumamoto, 860-0814, Japan
-
Research Site
Meguro-ku, 153-0061, Japan
-
Research Site
Meguro-ku, 153-8515, Japan
-
Research Site
Minatoku, 105-8471, Japan
-
Research Site
Moriguchi-shi, 570-0074, Japan
-
Research Site
Nagaoka-shi, 940-2085, Japan
-
Research Site
Osaka, 540-0008, Japan
-
Research Site
Shinjuku-ku, 160-0017, Japan
-
Research Site
Yoshida-gun, 910-1193, Japan
-
Research Site
Bydgoszcz, 85-231, Poland
-
Research Site
Elblag, 82-300, Poland
-
Research Site
Krakow, 31-513, Poland
-
Research Site
Lublin, 20-552, Poland
-
Research Site
Nadarzyn, 05-830, Poland
-
Research Site
Poznan, 60-805, Poland
-
Research Site
Wroclaw, 53-301, Poland
-
Research Site
Łodź, 90-153, Poland
-
Research Site
Izhevsk, 426061, Russia
-
Research Site
Penza, 440067, Russia
-
Research Site
Saint Petersburg, 196158, Russia
-
Research Site
Taipei, 10002, Taiwan
-
Research Site
Taipei, 110, Taiwan
-
Research Site
Taipei, 11217, Taiwan
-
Research Site
Taipei, 114, Taiwan
-
Research Site
Taipei, 235, Taiwan
-
Research Site
Taoyuan, 333, Taiwan
-
Research Site
Bangkok, 10330, Thailand
-
Research Site
Bangkok, 10400, Thailand
-
Research Site
Bangkok, 10700, Thailand
-
Research Site
Chiang Mai, 50200, Thailand
-
Research Site
Khon Kaen, 40002, Thailand
-
Research Site
Phitsanulok, 65000, Thailand
-
Research Site
Aydin, 09100, Turkey (Türkiye)
-
Research Site
Bakırköy, 34147, Turkey (Türkiye)
-
Research Site
Izmir, 35340, Turkey (Türkiye)
-
Research Site
Malatya, 44280, Turkey (Türkiye)
-
Research Site
Hanoi, 100000, Vietnam
-
Research Site
Ho Chi Minh City, 700000, Vietnam